Apogem Capital LLC Rocket Pharmaceuticals, Inc. Transaction History

Apogem Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $81,802 - $121,745	-6,613 Reduced 31.99%	14,056 $224,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $43,429 - $90,787	5,456 Added 35.86%	20,669 $284,000
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $72,998 - $131,352	5,547 Added 57.39%	15,213 $241,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $208,012 - $348,169	9,666 New	9,666 $211,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.